dc.creatorDing, Xitao
dc.creatorZhang, Qingwei
dc.creatorWang, Zhiyi
dc.creatorLin, Guanyang
dc.date2012
dc.date2012-05-17T19:50:26Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/18144
dc.identifierhttp://www.latamjpharm.org/resumenes/31/2/LAJOP_31_2_2_4.pdf
dc.identifierissn:0326-2383
dc.descriptionA selective liquid chromatography-mass spectrometry (LC–MS) method for determination of febuxostat in rat plasma was developed and validated. After addition of midazolam as internal standard (IS), protein precipitation by acetonitrile was used as sample preparation, and chromatography involved Agilent SB-C18 column (2.1 x150 mm, 5 μm) using 0.1% formic acid in water and acetonitrile as a mobile phase with gradient elution. Detection involved positive ion mode electrospray ionization (ESI), and selective ion monitoring (SIM) mode was used for quantification of target fragment ions m/z 317 for febuxostat and m/z 326 for midazolam (internal standard, IS). The assay was linear over the range of 10-2000 ng/mL for febuxostat, with a lower limit of quantitation (LLOQ) of 10 ng/mL for febuxostat. Intra- and inter-day RSDs were less than 15% and the accuracies were in the range of 93.8-111.9% for febuxostat. This developed method was successfully applied to determinate of febuxostat in rat plasma for pharmacokinetic study.
dc.descriptionColegio de Farmacéuticos de la Provincia de Buenos Aires
dc.formatapplication/pdf
dc.format321-325
dc.languageen
dc.relationLatin American Journal of Pharmacy
dc.relationvol. 31, no. 02
dc.subjectFarmacia
dc.titleDevelopment and Validation of Liquid Chromatography-Mass Spectrometry Method for Determination of Febuxostat in Rat Plasma and its Application
dc.typeArticulo
dc.typeComunicacion


Este ítem pertenece a la siguiente institución